Publicaciones en colaboración con investigadores/as de Hospital Infantil Universitario Niño Jesus de Madrid (43)

2024

  1. Position statement on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies, part 3: precautions in situations of surgery, fever, and opportunistic infections

    European Journal of Pediatrics, Vol. 183, Núm. 2, pp. 915-927

2023

  1. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain

    European Journal of Pediatrics, Vol. 182, Núm. 1, pp. 307-317

  2. Position statement on infection screening, prophylaxis, and vaccination in pediatric patients with rheumatic diseases and immunosuppressive therapies, part 2: infection prophylaxis

    European Journal of Pediatrics, Vol. 182, Núm. 9, pp. 4271-4284

  3. Setting priorities for an agenda within the Spanish pediatric emergency medicine research network

    European Journal of Pediatrics, Vol. 182, Núm. 8, pp. 3549-3558

  4. Treatments for multi-system inflammatory syndrome in children — discharge, fever, and second-line therapies

    European Journal of Pediatrics, Vol. 182, Núm. 1, pp. 461-466

2022

  1. Antibiotic Prescribing in Children Hospitalized With COVID-19 and Multisystem Inflammatory Syndrome in Spain: Prevalence, Trends, and Associated Factors

    Journal of the Pediatric Infectious Diseases Society, Vol. 11, Núm. 5, pp. 225-228

  2. Clinical spectrum of COVID-19 and risk factors associated with severity in Spanish children

    European journal of pediatrics, Vol. 181, Núm. 3, pp. 1105-1115

  3. Comparison of pneumonia features in children caused by SARS-CoV-2 and other viral respiratory pathogens

    Pediatric Pulmonology, Vol. 57, Núm. 10, pp. 2374-2382

  4. Correction to: Position statement of the Spanish society of pediatric rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: part 1 (screening) (European Journal of Pediatrics, (2022), 181, 6, (2343-2354), 10.1007/s00431-022-04418-7)

    European Journal of Pediatrics

  5. Dynamics of Reverse Transcription-Polymerase Chain Reaction and Serologic Test Results in Children with SARS-CoV-2 Infection

    Journal of Pediatrics, Vol. 241, pp. 126-132.e3

  6. Manifestations and clinical phenotypes are not specific enough to predict SARS-CoV-2 infection in symptomatic children

    Acta Paediatrica, International Journal of Paediatrics, Vol. 111, Núm. 10, pp. 1974-1977

  7. Oral saliva swab reverse transcription PCR for Covid-19 in the paediatric population

    Archives of Disease in Childhood, Vol. 107, Núm. 11, pp. 1051-1058

  8. Position statement of the Spanish Society of Pediatric Rheumatology on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies: Part 1 (screening)

    European Journal of Pediatrics, Vol. 181, Núm. 6, pp. 2343-2354

  9. Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort

    Clinical Rheumatology, Vol. 41, Núm. 12, pp. 3759-3768

  10. SARS-CoV-2 acute bronchiolitis in hospitalized children: Neither frequent nor more severe

    Pediatric pulmonology, Vol. 57, Núm. 1, pp. 57-65

  11. Safety and Acceptance of COVID-19 Vaccination After Multisystem Inflammatory Syndrome in Children (MIS-C) in Spain

    Journal of the Pediatric Infectious Diseases Society, Vol. 11, Núm. 10, pp. 471-473

  12. Sleep, chronotype, and behavior in adolescents with attention-deficit/hyperactivity disorder: Chronotype in attention deficit/hyperactivity disorder

    Archives de Pediatrie, Vol. 29, Núm. 4, pp. 277-280

  13. Staphylococcus aureus Community-acquired Pneumonia in Children After 13-Valent Pneumococcal Vaccination (2008-2018): Epidemiology, Clinical Characteristics and Outcomes

    The Pediatric infectious disease journal, Vol. 41, Núm. 5, pp. e235-e242

  14. Viruses and Mycoplasma pneumoniae are the main etiological agents of community-acquired pneumonia in hospitalized pediatric patients in Spain

    Pediatric pulmonology, Vol. 57, Núm. 1, pp. 253-263

2021

  1. A Bayesian Model to Predict COVID-19 Severity in Children

    Pediatric Infectious Disease Journal, Vol. 40, Núm. 8, pp. E287-E293